Drug Shortage Report for SCLERODEX
| Report ID | 138068 |
| Drug Identification Number | 02020939 |
| Brand name | SCLERODEX |
| Common or Proper name | Dextrose USP 250mg/mL with Sodium Chloride USP 100mg/mL |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE SODIUM CHLORIDE |
| Strength(s) | 250MG 100MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50 x 10mL vial / fiole |
| ATC code | C05BB |
| ATC description | ANTIVARICOSE THERAPY |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-04-26 |
| Estimated end date | 2021-06-18 |
| Actual end date | 2021-06-18 |
| Shortage status | Resolved |
| Updated date | 2021-06-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-06-22 | French | Compare |
| v6 | 2021-06-22 | English | Compare |
| v5 | 2021-05-14 | French | Compare |
| v4 | 2021-05-14 | English | Compare |
| v3 | 2021-04-27 | English | Compare |
| v2 | 2021-04-26 | French | Compare |
| v1 | 2021-04-26 | English | Compare |
Showing 1 to 7 of 7